Publication:
Pedmark® reduced the risk of cisplatin-induced ototoxicity in pediatric patients with hepatoblastoma, seen in a Turkish compassionate use treatment protocol

Simple item page
dc.contributor.authorCabi, Emel Ünal
dc.contributor.authorTacyıldız, Nurdan
dc.contributor.authorAtaseven, Eda
dc.contributor.authorSivrice, Ayşe Çiğdem
dc.contributor.authorSevinir, Betül
dc.contributor.authorBrock, Penelope
dc.contributor.authorBhattacharya, Ananya
dc.contributor.authorMorgan, Allison
dc.contributor.authorBaskin-Bey, Edwina
dc.contributor.authorAltınel, Serdar
dc.contributor.buuauthorSEVİNİR, BETÜL BERRİN
dc.contributor.departmentBursa Uludağ Üniversitesi/Tıp Fakültesi/Pediatri Anabilim Dalı.
dc.contributor.researcheridJXF-4694-2024
dc.date.accessioned2024-11-18T12:04:57Z
dc.date.available2024-11-18T12:04:57Z
dc.date.issued2023-11-01
dc.identifier.endpageS573
dc.identifier.issn1545-5009
dc.identifier.issueSupplement 8
dc.identifier.startpageS572
dc.identifier.urihttps://hdl.handle.net/11452/48018
dc.identifier.volume70
dc.identifier.wos001183650902354
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherWiley
dc.relation.journalPediatric Blood & Cancer
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectOncology
dc.subjectHematology
dc.subjectPediatrics
dc.titlePedmark® reduced the risk of cisplatin-induced ototoxicity in pediatric patients with hepatoblastoma, seen in a Turkish compassionate use treatment protocol
dc.typeMeeting Abstract
dspace.entity.typePublication
relation.isAuthorOfPublication8d125a37-7601-4609-8cb8-b07ccb1c11a4
relation.isAuthorOfPublication.latestForDiscovery8d125a37-7601-4609-8cb8-b07ccb1c11a4

Files

Collections

Yeni Yayınlar